Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Antithrombotic Management of Coronary Artery Disease Complicated with Atrial Fibrillation: Interpretation of 2020 Chinese Expert Consensus |
Yaling Han | General Hospital of Northern Theater Command |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Antithrombotic Management of Atrial Fibrillation Complicated with Coronary Artery Disease: Interpretation of 2019 AHA/ACC/HRS Guidelines |
Meilin Liu | Peking University First Hospital |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Antithrombotic Therapy in Patients with Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: Interpretation of the 2018 Updated North American Perspective |
Xiaozeng Wang | General Hospital of Northern Theater Command |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Interpretation of 2018 EHRA Expert Consensus on Antithrombotic Treatment of Atrial Fibrillation with ACS/PCI |
Jinqing Yuan | Fuwai Hospital Chinese Academy of Medical Sciences |
10:21-10:30 | 10:21-10:30 |
Discussion |